GBIO vs XPEV · rev $19.9M vs rev $895.7M
Generation Bio Co (GBIO) versus Xpeng Inc (XPEV) — a side-by-side from cached financials, not a winner call.
Generation Bio Co (GBIO) is a biotechnology company listed on US.
Xpeng Inc (XPEV) is a auto manufacturers company listed on US. It is led by Xiaopeng He.
Latest reported GBIO revenue for 2024-12-31 was $19.9M. Net income was -$131.7M. Revenue was up 236.9% from 2023-12-31 to 2024-12-31. GBIO currently screens at market cap $25.4M.
Latest reported XPEV revenue for 2020-12-31 was $895.7M. Net income was -$418.7M. XPEV currently screens at market cap $20.28B.
GBIO currently screens at market cap $25.4M. XPEV currently screens at market cap $20.28B.
Not investment advice. Open the GBIO and XPEV stock pages for the full models.
Not investment advice.